Smith & Nephew (SNNUF) FCF Margin (2009 - 2024)
Smith & Nephew (SNNUF) reported FCF Margin of 6.08% for Q4 2024, down 8.56% quarter-over-quarter from 6.65% in Q4 2022.
Smith & Nephew (SNNUF) FCF Margin (2009 - 2024) Analysis & Trends
Smith & Nephew has reported FCF Margin for 15 years, with the latest figure at 6.08% in Q4 2024.
- For the quarter ending Q4 2024, FCF Margin changed N/A year-over-year to 6.08%; the trailing twelve-month figure through Dec 2024 stood at 5.09% (changed N/A YoY), and the FY2025 full-year result was 13.82%, down 105.0% from the prior year.
- FCF Margin for Q4 2024 stood at 6.08%, down from 6.65% in the prior quarter.
- The five-year high for FCF Margin was 9.24% in Q4 2020, with the low at 6.08% in Q4 2024.
- Historically, FCF Margin has averaged 7.18% across 4 years, with a median of 6.69% in 2021.
- Annual changes were most pronounced in 2020 — FCF Margin plunged 718 bps — and 2022, when it fell 8 bps.
- Smith & Nephew's FCF Margin stood at 9.24% in 2020, then fell by 27 bps to 6.73% in 2021, then decreased by 1 bps to 6.65% in 2022, then slipped by 9 bps to 6.08% in 2024.
- The last three FCF Margin figures came in at 6.08% (Q4 2024), 6.65% (Q4 2022), and 6.73% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 15.44% |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.08% |
| Dec 31, 2022 | 6.65% |
| Dec 31, 2021 | 6.73% |
| Dec 31, 2020 | 9.24% |
| Dec 31, 2019 | 16.42% |
| Dec 31, 2018 | 14.22% |
| Dec 31, 2017 | 70.59% |
| Dec 31, 2016 | 33.16% |
| Dec 31, 2015 | 41.24% |
| Dec 31, 2014 | 34.05% |
| Sep 30, 2014 | 25.26% |
| Mar 31, 2014 | 40.35% |
| Dec 31, 2013 | 40.65% |
| Mar 31, 2013 | 43.15% |
| Dec 31, 2012 | 25.07% |
| Jun 30, 2012 | 28.77% |
| Mar 31, 2012 | 36.49% |
| Dec 31, 2011 | 10.94% |
| Sep 30, 2011 | 0.00% |
| Jun 30, 2011 | 0.00% |